Macys Inc SEC Filings

Paul Griscom, SVP and Controller of Macy's, Inc. (M), reported a sale of 12,843 shares of Macy's common stock on 09/11/2025 at an average price of $17.2601 per share. After the sale, Mr. Griscom beneficially owned 23,379 shares. The Form 4 was signed by an attorney-in-fact, indicating the filing was made under power of attorney.

Macy's, Inc. notice of proposed sale reports an intended sale of 12,843 shares of common stock through Charles Schwab on 09/11/2025 with an aggregate market value of $218,844.72. The filing shows total shares outstanding of 268,505,751, and the shares to be sold were acquired via restricted stock vesting and performance vesting between 09/04/2023 and 09/04/2024 from Macy's as compensation. The filer reports no securities sold in the past three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.

Macy's, Inc. (M) Form 144 notifies the proposed sale of 100,000 shares of common stock to be executed through Charles Schwab on 09/10/2025 with an aggregate market value listed at $1,721,000.00 and 268,505,751 shares outstanding. The filing lists a series of restricted and performance-based stock vestings from 03/21/2024 through 03/31/2025 that together account for the securities to be sold, and indicates the shares were received as compensation. The seller is identified as Danielle L. Kirgan with a prior sale on 09/05/2025 of 100,000 shares generating gross proceeds of $1,729,527.03. The notice includes the signer’s representation that no undisclosed material adverse information is known.

Macy's, Inc. quarterly report describes operating and financing activity through the 13 and 26 weeks ended August 2, 2025. The company details its omni-channel operations under Macy's, Bloomingdale's and Bluemercury and reports ongoing execution of its "A Bold New Chapter" strategy, including the Reimagine 125 store initiative that outperformed the fleet. Digital sales comprised ~31%–32% of net sales in the periods presented. The company changed inventory valuation in February 2024 to LIFO cost method and did not restate prior periods. It completed a $500 million private offering of 7.375% notes due 2033, used proceeds to fund tenders and redemptions totaling $587 million and recorded a $13 million extinguishment loss. The ABL facility was amended and extended to $2.1 billion maturing April 2030. Share repurchases totaled ~12.6 million shares for ~$151 million year-to-date. The filing highlights supply-chain, tariff and macro risks and adoption timelines for new FASB ASUs.

Danielle L. Kirgan, Executive Vice President and Chief HR Officer of Macy's, Inc. (M), sold 100,000 shares of Macy's common stock on 09/05/2025 at a weighted-average price of $17.2953 per share, with transaction prices ranging from $17.25 to $17.425. After the sale, the reporting person beneficially owned 286,161 shares. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/09/2025. The filing discloses the sale in multiple transactions and offers to provide detailed per-price quantities on request.

Macy's, Inc. (M) filed a Form 144 notifying a proposed sale of 200,000 shares of Common Stock through Charles Schwab & Co. with an aggregate market value of $3,448,000.00 and approximately 271,539,526 shares outstanding. The securities listed were acquired via restricted stock and performance restricted stock vesting on dates from 07/09/2021 through 03/23/2023 as compensation from Macy's, Inc. The filing shows no reported sales in the past three months and includes the seller's representation that they know of no undisclosed material adverse information.

Schedule 13G filed for MACYS INC (CUSIP 55616P104). FMR LLC reports beneficial ownership of 14,026,410.51 shares, representing 5.2% of Macy's common stock as of the event date 06/30/2025. Abigail P. Johnson is also reported with sole dispositive power over the same 14,026,410.51 shares. The filing is signed on 08/05/2025.

Addresses and roles: Issuer principal executive office is listed at 151 West 34th Street, New York, NY 10001. FMR LLC principal business office is 245 Summer Street, Boston, MA 02210. The statement affirms the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.

Other disclosures:

• No shared voting or dispositive power is reported.
• One or more other persons may have rights to dividends or proceeds but no other person's interest exceeds 5%.